Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: Clinical intervention with donepezil and venlafaxine

被引:39
作者
Bourgeois, James A.
Farzin, Faraz
Brunberg, James A.
Tassone, Flora
Hagerman, Paul
Zhang, Lin
Hessl, David
Hagerman, Randi
机构
[1] Univ Calif Davis, Med Ctr, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Med Ctr, Dept Radiol, Sacramento, CA 95817 USA
[3] Univ Calif Davis, Med Ctr, Dept Biochem & Mol Med, Sacramento, CA 95817 USA
[4] Univ Calif Davis, Med Ctr, Dept Neurol, Sacramento, CA 95817 USA
[5] Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA
[6] Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA
关键词
D O I
10.1176/appi.neuropsych.18.2.171
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The authors present a case of a patient with dementia with mood symptoms and multiple neurological manifestations of fragile X-associated tremor/ataxia syndrome ( FXTAS). Despite a gradually deteriorating neurological course, he was managed for 2 years with combination therapy of donepezil and venlafaxine, which resulted in improvement and relative stabilization of his psychiatric status. Psychiatrists are hereby alerted to the description of a novel dementia syndrome that may respond to pharmacological intervention commonly used for other dementias.
引用
收藏
页码:171 / 177
页数:7
相关论文
共 40 条
[1]  
Aarsland D, 1999, INT J GERIATR PSYCH, V14, P69, DOI 10.1002/(SICI)1099-1166(199901)14:1<69::AID-GPS888>3.0.CO
[2]  
2-C
[3]  
[Anonymous], 1968, Learn Disord, DOI DOI 10.1080/13803390591004428
[4]  
Brunberg JA, 2002, AM J NEURORADIOL, V23, P1757
[5]  
CUNNINGHAM LA, 1994, J CLIN PSYCHIAT, V55, P90
[6]   Premutation and intermediate-size FMR1 alleles in 10,572 males from the general population:: Loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles [J].
Dombrowski, C ;
Lévesque, S ;
Morel, ML ;
Rouillard, P ;
Morgan, K ;
Rousseau, F .
HUMAN MOLECULAR GENETICS, 2002, 11 (04) :371-378
[7]  
Doraiswamy PM, 1998, J CLIN PSYCHIAT, V59, P6
[8]  
Fahn S., RECENT DEV PARKINSON, V2, P153, DOI DOI 10.1002/ANA.410220556
[9]   Choosing appropriate antidepressant therapy in the elderly - A risk-benefit assessment of available agents [J].
Flint, AJ .
DRUGS & AGING, 1998, 13 (04) :269-280
[10]  
Geizer M, 1998, CAN J PSYCHIAT, V43, P421